HVCN1 and neoplasm: In a further work published by Bare et al., by means of an in-vivo modeling of tumor growth showed that the knock-out (KO) of Hv1 in MDA-MB-231 cells contributed to a reduction in its tumor size when injected in mice, compared to its wild-type (WT) counterpart (Bare et al., 2020).